Sun Pharma Canada Company Profile
What is the competitive landscape for SUN PHARMA CANADA
SUN PHARMA CANADA has one hundred and forty-one approved drugs.
There are three US patents protecting SUN PHARMA CANADA drugs.
Summary for Sun Pharma Canada
| US Patents: | 3 |
| Tradenames: | 65 |
| Ingredients: | 61 |
| NDAs: | 141 |
Drugs and US Patents for Sun Pharma Canada
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sun Pharma Canada | CLOTRIMAZOLE AND BETAMETHASONE DIPROPIONATE | betamethasone dipropionate; clotrimazole | LOTION;TOPICAL | 076493-001 | Jul 28, 2004 | AB | RX | No | Yes | ⤷ Start Trial | ⤷ Start Trial | ||||
| Sun Pharma Canada | NAFTIFINE HYDROCHLORIDE | naftifine hydrochloride | CREAM;TOPICAL | 205975-001 | Sep 8, 2016 | RX | No | Yes | ⤷ Start Trial | ⤷ Start Trial | |||||
| Sun Pharma Canada | DICLOFENAC SODIUM | diclofenac sodium | GEL;TOPICAL | 206298-001 | Apr 28, 2016 | AB | RX | No | Yes | ⤷ Start Trial | ⤷ Start Trial | ||||
| Sun Pharma Canada | ORALONE | triamcinolone acetonide | PASTE;DENTAL | 071383-001 | Jul 6, 1987 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| Sun Pharma Canada | RANITIDINE HYDROCHLORIDE | ranitidine hydrochloride | SYRUP;ORAL | 077476-001 | Jun 13, 2011 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| Sun Pharma Canada | IBUPROFEN | ibuprofen | SUSPENSION;ORAL | 209204-001 | Jun 23, 2017 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Sun Pharma Canada
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Sun Pharma Canada | FLO-PRED | prednisolone acetate | SUSPENSION;ORAL | 022067-001 | Jan 17, 2008 | 6,102,254 | ⤷ Start Trial |
| Sun Pharma Canada | FLO-PRED | prednisolone acetate | SUSPENSION;ORAL | 022067-002 | Jan 17, 2008 | 6,656,482 | ⤷ Start Trial |
| Sun Pharma Canada | TOPICORT | desoximetasone | SPRAY;TOPICAL | 204141-001 | Apr 11, 2013 | 5,990,100 | ⤷ Start Trial |
| Sun Pharma Canada | FLO-PRED | prednisolone acetate | SUSPENSION;ORAL | 022067-002 | Jan 17, 2008 | 6,071,523 | ⤷ Start Trial |
| Sun Pharma Canada | FLO-PRED | prednisolone acetate | SUSPENSION;ORAL | 022067-002 | Jan 17, 2008 | 6,102,254 | ⤷ Start Trial |
| Sun Pharma Canada | FLO-PRED | prednisolone acetate | SUSPENSION;ORAL | 022067-002 | Jan 17, 2008 | 5,881,926 | ⤷ Start Trial |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Paragraph IV (Patent) Challenges for SUN PHARMA CANADA drugs
| Drugname | Dosage | Strength | Tradename | Submissiondate |
|---|---|---|---|---|
| ➤ Subscribe | Topical Spray | 0.25% | ➤ Subscribe | 2013-12-18 |
International Patents for Sun Pharma Canada Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| New Zealand | 566117 | ⤷ Start Trial |
| World Intellectual Property Organization (WIPO) | 2007019184 | ⤷ Start Trial |
| South Korea | 20080044245 | ⤷ Start Trial |
| Japan | 2013014634 | ⤷ Start Trial |
| Australia | 2006278620 | ⤷ Start Trial |
| European Patent Office | 1888026 | ⤷ Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Sun Pharma Canada Drugs
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 0591275 | SPC/GB05/030 | United Kingdom | ⤷ Start Trial | PRODUCT NAME: NITISINONE (2-(2-NITRO-4-TRIFLUOROMETHYLBENZOYL)-1,3-CYCLOHEXANEDIONE) OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF; REGISTERED: UK EU/1/04/303/001 20050221; UK EU/1/04/303/002 20050221; UK EU/1/04/303/003 20050221 |
| 2435024 | 301102 | Netherlands | ⤷ Start Trial | PRODUCT NAME: COMBINATIE VAN FORMOTEROL (MET INBEGRIP VAN DE FARMACEUTISCH AANVAARDBARE ZOUTEN, ESTERS, SOLVATEN OF ENANTIOMEREN ERVAN), GLYCOPYRROLAAT (MET INBEGRIP VAN DE FARMACEUTISCH AANVAARDBARE ZOUTEN, ESTERS, SOLVATEN OF ENANTIOMEREN ERVAN) EN BUDESONIDE (MET INBEGRIP VAN DE FARMACEUTISCH AANVAARDBARE ZOUTEN, ESTERS, SOLVATEN OF ENANTIOMEREN ERVAN); REGISTRATION NO/DATE: EU/1/20/1498 20201210 |
| 2435024 | 2021C/518 | Belgium | ⤷ Start Trial | PRODUCT NAME: UNE COMBINAISON DE FORMOTEROL (Y COMPRIS TOUS SES SELS, ESTERS, SOLVATES OU ENANTIOMERES PHARMACEUTIQUEMENT ACCEPTABLES), GLYCOPYRROLATE (Y COMPRIS TOUS SES SELS, ESTERS, SOLVATES OU ENANTIOMERES PHARMACEUTIQUEMENT ACCEPTABLES) ET BUDESONIDE (Y COMPRIS TOUS SES SELS, ESTERS, SOLVATES OU ENANTIOMERES PHARMACEUTIQUEMENT ACCEPTABLES); AUTHORISATION NUMBER AND DATE: EU/1/20/1498 20201210 |
| 1304992 | 132013902214376 | Italy | ⤷ Start Trial | PRODUCT NAME: CLINDAMICINA FOSFATO E TRETINOINA(ACNATAC); AUTHORISATION NUMBER(S) AND DATE(S): PA1332/043/001, 20130322;042056010/M - 022/M, 20130718 |
| 0137963 | 97C0042 | Belgium | ⤷ Start Trial | PRODUCT NAME: 2-(2-BENZOYL-SUBSTITUE)-1,3-CYCLOHEXANE-DIONES; REGISTRATION NO/DATE: 8452/B 19930121 |
| 2435024 | LUC00208 | Luxembourg | ⤷ Start Trial | PRODUCT NAME: COMBINAISON DE FORMOTEROL (Y COMPRIS SES SELS, ESTERS, SOLVATES OU ENANTIOMERES PHARMACEUTIQUEMENT ACCEPTABLES), DE GLYCOPYRRONIUM (Y COMPRIS SES SELS, ESTERS, SOLVATES OU ENANTIOMERES PHARMACEUTIQUEMENT ACCEPTABLES) ET DE BUDESONIDE (Y COMPRIS SES SELS, ESTERS, SOLVATES OU ENANTIOMERES PHARMACEUTIQUEMENT ACCEPTABLES); AUTHORISATION NUMBER AND DATE: EU/1/20/1468 20201210 |
| >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
